189P Safety Run-in Results from LEAP-014: First-line Lenvatinib (len) Plus Pembrolizumab (pembro) and Chemotherapy (chemo) for Metastatic Esophageal Squamous Cell Carcinoma (ESCC)
Annals of Oncology（2023）
Key words
Combination Therapies
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined